Premera Blue Cross · Identified Jun 18, 2026Medium impact
Medical Policy and Coding Updates - January 2021
Effective January 1, 2021, Immune Globulin Therapy criteria changed so that preventive IVIG use after hematopoietic cell transplantation, in chronic lymphocytic leukemia, lymphoma, multiple myeloma and solid organ transplant became investigational, and IVIG for humoral immunodeficiency states now requires an IgG level below 400 mg/dL with persistent or recurrent infections. Effective January 1, 2021, the Drugs for Weight Management policy was added for Contrave, Qsymia, Saxenda and Xenical for groups that cover weight loss drugs, and the Exception Request policy for Washington fully insured members was added. Coding updates made CPT 69705, 69706 and 55880, and HCPCS Q5122, J9316, J7352, J0638 and J1823 subject to medical necessity and prior authorization review, and made the listed AIM genetic testing codes subject to prior authorization starting January 1, 2021.